Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leqembi
Biogen's monoclonal antibody for Alzheimer's disease.
Marketing
Analysts tip Lilly to drive eightfold Alzheimer's market boom
GlobalData analysts predict the value of the Alzheimer's market across major regions will increase eightfold as therapies address unmet medical need.
Nick Paul Taylor
Jan 17, 2025 9:00am
EU regulators endorse meds from BMS, J&J, Eisai and more
Nov 15, 2024 10:05am
EMA changes tune, endorses Leqembi with restriction
Nov 14, 2024 12:10pm
AstraZeneca, GSK, Takeda—Fierce Pharma Asia
Nov 1, 2024 8:20am
Biogen raises profit guidance as Leqembi's launch trudges on
Oct 30, 2024 12:30pm
Lilly's adjusted Kisunla regimen reduces brain swelling in trial
Oct 29, 2024 3:38pm